Bill
HR 2161
The Human-Animal Chimera Prohibition Act bans creating human-animal chimeras, restricting federal funding for related research to protect ethical standards in biotechnology.
The Human-Animal Chimera Prohibition Act of 2025 aims to prohibit the creation, use, or experimentation involving human-animal chimeras. The bill reflects growing ethical concerns regarding the blending of human and animal genetic material, particularly in research and medical contexts. The intent is to safeguard human dignity and prevent potential abuses in genetic engineering.
The bill includes several critical provisions:
Prohibition of Chimeras: It explicitly bans the creation of chimeras that contain human cells or genetic material in non-human animals. This includes any organism that has been genetically modified to include human DNA.
Research Restrictions: The bill restricts federal funding for any research that involves the creation or use of human-animal chimeras. This aims to ensure that taxpayer dollars are not used to support controversial genetic experiments.
Penalties: The legislation outlines penalties for violations, which may include fines and restrictions on future funding for institutions found to be in breach of the law.
The bill primarily impacts:
Research Institutions: Universities and laboratories engaged in genetic research may need to alter their research agendas and funding applications to comply with the new restrictions.
Biotechnology Companies: Companies involved in genetic engineering and related fields may face limitations on their research and development activities.
Ethical and Advocacy Groups: Organizations advocating for ethical standards in biotechnology may support the bill, while those focused on scientific advancement may oppose it.
Introduced: The bill was introduced in the House of Representatives on March 14, 2025.
Referred to Committee: On the same day, it was referred to the House Committee on the Judiciary for further consideration.
The bill is currently in the early stages of the legislative process, and its future will depend on discussions and potential amendments within the committee.
HR 2161 represents a significant legislative effort to address ethical concerns surrounding genetic engineering and the creation of human-animal chimeras. As it progresses through the legislative process, it will likely spark debates on the balance between scientific innovation and ethical considerations in biotechnology.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
